Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 20, 2018 02:00 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Preliminary confirmation of safety read-out from the fimaChem Phase I extension study in bile duct cancer

Oslo (Norway), 20 December 2018 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announced preliminary confirmation that the safety endpoint has been reached in the Phase I...
December 18, 2018 08:55 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Extension of preclinical research collaboration agreement with a top-10 large pharma company

Oslo (Norway), 18 December 2018 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announced that they are extending the preclinical research collaboration with an undisclosed...
November 13, 2018 01:30 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Third quarter 2018 results

Oslo (Norway), 13 November 2018 - PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announces its interim third quarter 2018 result. Please find enclosed the report and...
November 06, 2018 02:00 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Invitation to third quarter 2018 presentation

Oslo, Norway, 06 November 2018 - PCI Biotech invites to a presentation of the company's third quarter 2018 report on Tuesday 13 November 2018 at Oslo Cancer Cluster Innovation Park. Time: Tuesday...
October 24, 2018 05:01 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Capital increase registered and listing of new shares

Oslo, Norway, 24 October 2018. Reference is made to the previous announcements by PCI Biotech Holding ASA ("PCI Biotech" or the "Company") in respect of the issuance of 170,000 new shares following...
October 19, 2018 04:03 ET | Source: PCI Biotech Holding ASA

PCI Biotech to present Phase I dose escalation results at ESMO

Oslo, Norway, 19 October 2018 — PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announced that the company will present results from the Phase I dose escalation study in...
October 17, 2018 12:48 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Exercise of employee share options, mandatory noticifation of trade and resolution to increase share capital

Oslo (Norway), 17 October 2018 – Exercise of employee share options, mandatory notification of trade and resolution to increase the share capital in PCI Biotech Holding ASA (the “Company”). 1. ...
October 10, 2018 08:21 ET | Source: PCI Biotech Holding ASA

Disclosure of large shareholding

Bergen, 10 October 2018 – reference is made to the previous announcement on 24 September 2018 regarding the disclosure of large shareholdings in relation to the rights issue in PCI Biotech Holding ASA...
October 10, 2018 03:20 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Capital increase registered and listing of new shares

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, HONG KONG OR SOUTH AFRICA, OR...
October 04, 2018 06:44 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Final results of the rights issue

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, HONG KONG OR SOUTH AFRICA, OR...